| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.49 | 5e-24 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.08 |